Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 Certificate of Conversion (Texas)
- 3.1 Certificate of Conversion (Delaware)
- 3.1 Certificate of Incorporation
- 3.1 Bylaws
- 4.1 Form of Warrant (2014)
- 4.1 Form of Warrant (2017)
- 4.1 Form of Warrant (2019)
- 10.1 Amended and Restated 2018 Equity Incentive Plan
- 10.2 Employment Agreement Dated July 23, 2018 with Panna Sharma
- 10.3 Form of Indemnification Agreement
- 10.4 Amended and Restated Investors' Rights Agreement
- 10.5 Amended and Restated Right of First Refusal and Co-sale Agreement
- 10.6 Amended and Restated Voting Agreement
- 10.7 Technology License Agreement Dated January 15,2015, with Af Chemicals LLC
- 10.8 Drug License and Development Agreement Dated As of May 23, 2015 with Oncology Venture A/s
- 10.9 Addendum to Drug License and Development Agreement with Oncology Venture A/s Dated February 8, 2016
- 10.10 Amendment No. 2 to Drug License and Development Agreement with Oncology Venture A/s Dated February 11, 2016
- 10.11 Assignment Agreementdated As of January 5, 2018 with Bionumerik Pharmaceuticals, Inc
- 10.12 Addendum to Technologylicense Agreement Dated February 8, 2016, with Af Chemicals, LLC
- 14.1 Code of Business Conduct and Ethics
- 21.1 List of Subsidiary
- 23.1 Consent of Eisneramper LLP, Independent Registered Public Accounting Firm
Associated filings
LTRN similar filings
Filing view
External links